Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LHX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY19L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF561-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SERF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMSS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PHF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF271P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC167 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABL2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ISYNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHRS4L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on